Clinical biology of the Barrett's metaplasia, dysplasia to carcinoma sequence

Surgical Oncology

Volumn 10, Issue 3, 2001, Pages 91-102

  DeMeester, T R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGRICULTURAL CHEMICAL; ALCOHOL; BILIRUBIN; CARCINOGEN; CIMETIDINE; COSMETIC; DIAZEPAM; HYDROXYZINE; INDUSTRIAL CHEMICAL; MUTAGENIC AGENT; NITROSAMINE; WATER;

ARTICLE; BARRETT ESOPHAGUS; BIOLOGY; CANCER GROWTH; CANCER RISK; CELL DAMAGE; COLUMNAR EPITHELIUM; DNA DAMAGE; DYSPLASIA; EPITHELIUM DYSPLASIA; ESOPHAGUS; ESOPHAGUS CARCINOMA; GASTROESOPHAGEAL REFLUX; HEART; HUMAN; INTESTINE METAPLASIA; LOWER ESOPHAGUS SPHINCTER; MUCOSA; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; SQUAMOUS CELL METAPLASIA; SQUAMOUS EPITHELIUM; TOBACCO;

EID: 0035677685     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-7404(01)00030-5     Document Type: Short Survey

References (61)

1. Barrett's esophagus: Development of dysplasia and adenocarcinoma
2. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus
3. A guide for surveillance of patients with Barrett's esophagus
4. Barrett's esophagus: Age, prevalence, and extent of columnar epithelium
5. Inflammation and metaplasia in the transitional epithelium of the gastroesophageal junction: A new marker for gastroesophageal reflux disease
6. Prevalence of metaplasia at the gastroesophageal junction
7. Gastric pathology as an initiator and potentiator of gastroesophageal reflux disease
8. The lower end of the esophagus
9. Histology of the gastroesophageal junction: An autopsy study
10. Definition of histopathologic changes in gastroesophageal reflux disease
11. Barrett's esophagus: Congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog
12. Experimental columnar metaplasia in the canine esophagus
13. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease
14. Location of the lower esophageal sphincter and the squamous columnar mucosal junction in 109 healthy controls and 778 patients with different degrees of endoscopic esophagitis
15. Metaplastic columnar mucosa in the cervical esophagus following esophagectomy
16. Biology of gastroesophageal reflux disease: Pathophysiology relating to medical and surgical treatment
17. Mechanisms of columnar metaplasia and squamous regeneration in experimental Barrett's esophagus
18. The frequency of specialized intestinal metaplasia at the squamo-columnar junction varies with the extent of columnar epithelium lining the esophagus
19. The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure
20. Endoscopic surveillance of columnar-lined esophagus: Frequency of intestinal metaplasia detection and impact of antireflux surgery
21. Barrett's esophagus in children: A histologic and histochemical study of 11 cases
22. Intestinal metaplasia is age related in Barrett's esophagus
23. Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology outcomes research group in endoscopy
24. Regeneration of cardiac type mucosa and acquisition of Barrett's mucosa after esophago-gastrostomy
25. Gastroduodenal function in Barrett's esophagus
26. Implication of duodenogastric reflux in the pathogenesis of Barrett's esophagus
27. Complications of gastroesophageal reflux disease: Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux
28. Assessment of combined bile acid and pH profiles using an automated sampling devise in gastro-oesophageal reflux disease
29. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone: The need for surgical therapy re-emphasized
30. Determinants of interstinal metaplasia within the columnar-lined esophagus
31. Predictive factors of Barrett's esophagus - Multivariate analysis of 502 patients with GERD
32. Dynamic effects of acid on Barrett's esophagus: An ex vivo proliferation and differentiation model
33. Distribution and significance of epithelial types in columnar lined esophagus
34. Factors influencing villus size in the small intestine of adult rats as revealed by transposition of intestinal segments
35. Contributions of bile and pancreatic juice to cell proliferation in ileal mucosa
36. The impact of an antireflux procedure on intestinal metaplasia of the cardia
37. Bile reflux in benign and malignant Barrett's esophagus: Effect of medical acid suppression and nissen fundoplication
38. Duodenogastric reflux potentiates the injurious effects of gastroesophageal reflux
39. Intestinal metaplasia in patients with columnar lined esophagus is associated with high levels of duodenogastroesophageal reflux
40. Bile acid accumulation by rabbit esophageal mucosa
41. Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes; role of ATP depletion and cytosolic free calcium
42. Bile acids: Co-mutagenic activity in the salmonella-mammalian-microsome mutagenicity test: Brief communication
43. The mutagenic potential of duodeno-esophageal reflux
44. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure
45. Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats
46. Gastric juice protects against the development of esophageal adenocarcinoma in the rat
47. Esophagitis in Sprague-Dawley rates is mediated by free radicals
48. Free radical scavengers prevent reflux esophagitis in rats
49. Reflux esophagitis in humans is mediated by oxygen-derived free radicals
50. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
51. Oxidative damage in an esophageal adenocarcinoma model with rats
52. Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole
53. Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation
54. Effect of cimetidine on gastric juice N-nitrosamine concentration
55. Metabolism of carcinogenic nitrosamines in the rate and human esophagus and induction of esophageal adenocarcinoma in rats
56. The etiology of gastric cancer: Intragastric nitrosamide formation and other theories
57. N-nitroso bile acid conjugates. 1. Synthesis, chemical reactivity and mutagenic acticity
58. Columnar mucosa and intestinal metaplasia of the esophagus: Fifty years of controversy
59. Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease